Average Co-Inventor Count = 3.91
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance Biopharma R&d IP, LLC (10 from 262 patents)
2. Merck Sharp + Dohme Corp. (2,405 patents)
10 patents:
1. 11878977 - JAK inhibitors containing a 4-membered heterocyclic amide
2. 11786517 - Methods of treatment using a JAK inhibitor compound
3. 11667637 - Fused imidazo-piperidine JAK inhibitors
4. 10550118 - JAK inhibitors containing a 4-membered heterocyclic amide
5. 10548886 - Methods of treatment using a JAK inhibitor compound
6. 10519153 - Fused imidazo-piperidine JAK inhibitors
7. 10406148 - Methods of treatment using a JAK inhibitor compound
8. 10392386 - JAK inhibitors containing a 4-membered heterocyclic amide
9. 10251874 - Crystalline forms of a JAK inhibitor compound
10. 10208040 - Fused imidazo-piperidine JAK inhibitors